Subscribe

0

Piramal Pharma

Piramal Pharma Limited InFocus

Piramal Pharma Q3FY25 Revenue Rises 13%, EBITDA Up 6%

Nandini Piramal, Chairperson, Piramal Pharma Limited said, “FY25 so far has been a steady year for the Company with revenue growth of 14% and EBITDA growing at 20%.

By SMEStreet Edit Desk
Jan 29, 2025 10:20 IST 4 Min read
ajay piramal, Piramal Group, NBFC, InFocus
Piramal Pharma Ltd. to Acquire Manufacturer of peptide APIs Hemmo Pharmaceuticals
By SMEStreet Edit Desk
Apr 01, 2021 06:15 IST 2 Min read
CoVID-19 Vaccine, COVID Pandemic, Coronavirus LimeLight
CCI Approves Acquisition of Piramal Pharma's 20% Stakes Acquisition by CA Clover Intermediate
By SMEStreet Edit Desk
Sep 12, 2020 08:08 IST 1 Min read